NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform
The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.
A €4.3 million EU grant is supporting the German firms' work on AI technology to accelerate precision oncology.
Indivumed, CellPhenomics Partner on Cancer Drug Target Research
The two German companies will share tumor data for AI-based in silico target discovery and in vitro validation.
MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics
As part of the initiative, MDIC will manufacture, validate, and distribute reference samples to support the validation of NGS-based cancer diagnostics.
Israeli researchers have developed CRISPector, which separates signal from noise better than earlier quality-control tools, a new paper shows.